Cargando…
Is letrozole during ovarian stimulation useful in breast cancer patients undergoing fertility preservation to reduce early luteal progesterone levels following GnRH-agonist trigger?
BACKGROUND: In absence of contraindication, breast cancer patients of reproductive age can undergo fertility preservation with controlled ovarian stimulation for oocyte/embryo cryopreservation before the administration of potentially gonadotoxic treatments. High hormonal levels induced by ovarian st...
Autores principales: | Lalami, Imane, Labrosse, Julie, Cedrin-Durnerin, Isabelle, Comtet, Marjorie, Vinolas, Claire, Krief, Fabien, Sifer, Christophe, Peigne, Maeliss, Grynberg, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9188055/ https://www.ncbi.nlm.nih.gov/pubmed/35690817 http://dx.doi.org/10.1186/s12958-022-00958-7 |
Ejemplares similares
-
Comparison of GnRH agonist versus luteal estradiol
GnRH antagonist protocol using transdermal testosterone in poor
responders
por: Fàbregues, Francesc, et al.
Publicado: (2019) -
Effect of Endometrium Thickness on Clinical Outcomes in Luteal Phase Short-Acting GnRH-a Long Protocol and GnRH-Ant Protocol
por: Zhang, Jie, et al.
Publicado: (2021) -
A comparison of the effects of three luteal phase support protocols
with estrogen on in vitro fertilization-embryo transfer
outcomes in patients on a GnRH antagonist protocol
por: Scheffer, Juliano Brum, et al.
Publicado: (2019) -
Luteal blood flow in patients undergoing GnRH agonist long protocol
por: Takasaki, Akihisa, et al.
Publicado: (2011) -
Impact of Mid-Luteal Phase GnRH Agonist Administration on Reproductive Outcomes in GnRH Agonist-Triggered Cycles: A Randomized Controlled Trial
por: Benmachiche, Abdelhamid, et al.
Publicado: (2017)